SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)                October 7, 1996




                           BARRINGER TECHNOLOGIES INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)



      Delaware                            0-3207                      84-0720473
- --------------------------------------------------------------------------------
(State or other jurisdiction of         (Commission                (IRS Employer
  incorporation or organization)         File Number)        Identification No.)



               219 South Street, New Providence, New Jersey 07974
- --------------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)



Registrant's telephone number, including area code:               (908) 665-8200





Item 5.  Other Events.

     On  October  7, 1996,  Barringer  Technologies  Inc.  (the  "Company")  and
Barringer Laboratories, Inc. ("Labco") entered into a Termination Agreement (the
"Agreement"),  pursuant to which, among other things,  Labco agreed to waive its
right of first  refusal and to  terminate  certain  restrictions  regarding  the
transfer of 437,475  shares of Labco  common  stock  owned by the  Company  (the
"Shares").  The Company had agreed to such  restrictions  in connection with the
Company's sale to Labco of 647,238 shares of Labco's common stock owned by it in
December 1995.  The Company agreed in the Agreement  that, for a period of three
months from the date of the Agreement, it would sell the Shares at a price of at
least $1.6875 per share (the "Target Price") in a distribution in which it would
not  knowingly  sell more than 75,000  shares to any one  purchaser  or group of
related  purchasers.  Under the  Agreement,  for such  three-month  period,  the
Company  must sell the Shares as  provided  above,  if it  receives  an offer to
acquire the Shares at a price per share at least equal to the Target Price.  The
restrictions  also apply to any shares of Labco  common  stock  issuable  to the
Company upon the  exercise of certain  warrants  held by the Company.  Labco has
registered  the Shares for resale  pursuant to the  Securities  Act of 1933,  as
amended, to facilitate such sales.

     In the Agreement, the Company agreed to surrender to Labco 88,260 shares of
Labco common stock owned by the Company which Labco had the right to retain,  in
certain  circumstances,  in  connection  with the 1995 sale and to terminate all
remaining inter-company arrangements between the Company and Labco. In addition,
upon the  disposition by the Company of at least 250,000 of the Shares,  Stanley
S. Binder,  a Director of Labco, and John J. Harte, the Chairman of the Board of
Labco, will resign their respective positions with Labco.

Item 7.  Financial Statements and Exhibits.

         (c) Exhibits.

Exhibit 28.1  Termination Agreement, dated  October  7,  1996,  by  and between 
              Barringer Laboratories, Inc. and Barringer Technologies Inc.







                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                                             BARRINGER TECHNOLOGIES INC.

                                             By:/s/Stanley S. Binder
                                                ________________________________
                                                   Stanley S. Binder,
                                                   President and Chief Executive
                                                      Officer

Dated:  October 10, 1996





                                  EXHIBIT INDEX

Exhibit                                                                 Page No.

28.1 Termination  Agreement,  dated  October 7, 1996,  by 
     and between  Barringer Laboratories, Inc. and Barringer 
     Technologies Inc.*








*   Incorporated  by reference to Exhibit 10.11  to  the Company's  Registration
    Statement on Form SB-2, File No. 333-13703.